Inactive Instrument
Isodiol International Inc Share Price Canadian Securities Exchange
Stocks
CA46500L1013
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.91M 2.73M 2.49M 2.29M 2.08M 253M 4.11M 27.9M 11.09M 138M 10.25M 10.03M 434M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.38M 5.81M 5.35M 4.87M 591M 9.6M 65.14M 25.89M 323M 23.93M 23.42M 1.01B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | -3.58% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 23/05/2017 |
| Corporate Officer/Principal | - | 29/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 23/05/2017 |
| Director/Board Member | - | 29/08/2018 | |
| Director/Board Member | - | 20/11/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.58% | +881.08% | - | - | 128 | ||
| -0.30% | -6.68% | +27.12% | +127.32% | 1,200B | ||
| +1.25% | -5.35% | +32.65% | +78.98% | 651B | ||
| +0.94% | -2.99% | +21.13% | +106.30% | 506B | ||
| -0.60% | -1.95% | +25.73% | +67.00% | 377B | ||
| +0.69% | -9.50% | +36.78% | +30.83% | 330B | ||
| +0.41% | -4.70% | +24.18% | +50.18% | 288B | ||
| +0.81% | -4.08% | -2.95% | +31.59% | 272B | ||
| -0.15% | -6.45% | +29.06% | +65.76% | 236B | ||
| -0.06% | -0.98% | +31.42% | +122.83% | 206B | ||
| Average | -0.06% | -4.76% | +25.01% | +75.64% | 452B | |
| Weighted average by Cap. | +0.30% | -5.19% | +26.02% | +87.88% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.36M 12.17M 11.21M 10.2M 1.24B 20.11M 136M 54.25M 676M 50.14M 49.08M 2.12B | 22.25M 15.53M 14.15M 13.04M 11.86M 1.44B 23.38M 159M 63.06M 786M 58.28M 57.06M 2.47B |
| Net income | -36.02M -25.15M -22.91M -21.11M -19.2M -2.33B -37.86M -257M -102M -1.27B -94.37M -92.38M -3.99B | -126M -87.92M -80.07M -73.78M -67.12M -8.14B -132M -898M -357M -4.45B -330M -323M -13.96B |
| Net Debt | -15.55M -10.86M -9.89M -9.11M -8.29M -1.01B -16.34M -111M -44.08M -549M -40.74M -39.88M -1.72B | 5.22M 3.65M 3.32M 3.06M 2.78M 338M 5.49M 37.24M 14.8M 184M 13.68M 13.39M 579M |
Employees
-
Sector
Pharmaceuticals
















